Clinical, Radiological, and Histopathological Characteristics of a Patient with a Pituitary Tumor of the Corticotrophinoma Type — Case Report
DOI:
https://doi.org/10.15225/PNN.2023.12.3.5Keywords
Cushing disease, hypercortisolism, pituitary tumorAbstract
Introduction. Cushing disease is a rare but severe endocrine disorder. It is caused by a pituitary tumor producing excessive amounts of adrenocorticotropic hormone (ACTH) which is subsequently responsible for excessive production of cortisol in the adrenal glands. Hypercortisolism manifests with many symptoms and disorders that affect numerous organs.
Aim. To increase knowledge among nursing staff about the symptoms, causes, and treatment of patients with Cushing disease.
Case Report. A 40-year-old patient with a history of infertility treatment was admitted to the Clinical Department of Neurosurgery of St. Raphael Hospital in Krakow due to a pituitary tumor. For 7 years the patient had been experiencing symptoms such as weight gain, excessive tiredness, and menstrual disorders. The MRI examination of the pituitary showed a tumor in the sella turcica with dimensions of 4.5×5.5×4.5 mm. The histopathological examination revealed corticotropic pituitary adenoma (positive for ACTH). The patient underwent surgery after which symptoms of hypercortisolism decreased and menstruation returned. The patient became pregnant and gave birth to a child.
Discussion. A proper diagnosis in this patient’s case could protect her from development of many complications related to other organs, such as diabetes mellitus or hypertension.
Conclusions. Cushing disease remains in some cases undiagnosed for many years. The patient is being referred to various specialists (ophthalmologist, gynecologist, rheumatologist) due to symptoms that are in fact complications of hypercortisolism. The case illustrates the importance of early recognition of the main symptoms of hypercortisolism. Such clinical skill would undeniably help to refer the patient to the appropriate specialist, i.e., an endocrinologist much earlier, and thus establish the correct diagnosis and implement appropriate treatment. (JNNN 2023;12(3):134–139)
References
Lacroix A., Feelders R.A., Stratakis C.A., Nieman L.K. Cushing’s syndrome. Lancet. 2015;386(9996):913–927.
Rubinstein G., Osswald A., Hoster E. et al. Time to Diagnosis in Cushing’s Syndrome: A Meta-Analysis Based on 5367 Patients. J Clin Endocrinol Metab. 2020;105(3):dgz136.
McBride M., Crespo I., Webb S.M., Valassi E. Quality of life in Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101505.
Pivonello R., Isidori A.M., De Martino M.C., Newell-Price J., Biller B.M., Colao A. Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611–629.
Giordano R., Picu A., Marinazzo E. et al. Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission. Clin Endocrinol (Oxf). 2011;75(3):354–360.
Varlamov E.V., Langlois F., Vila G., Fleseriu M. Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach. Eur J Endocrinol. 2021;184(5):R207–R224.
Shekhar S., McGlotten R., Auh S., Rother K.I., Nieman L.K. The Hypothalamic-Pituitary-Thyroid Axis in Cushing Syndrome Before and After Curative Surgery. J Clin Endocrinol Metab. 2021;106(3):e1316–e1331.
van der Pas R., de Bruin C., Leebeek F.W. et al. The hypercoagulable state in Cushing’s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab. 2012;97(4):1303–1310.
Arnaldi G., Angeli A., Atkinson A.B. et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593–5602.
Nieman L.K., Biller B.M., Findling J.W. et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526–1540.
Nieman L.K., Biller B.M., Findling J.W. et al. Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807–2831.
Krzentowska-Korek A., Gołkowski F., Bałdys-Waligórska A., Hubalewska-Dydejczyk A. Efficacy and complications of neurosurgical treatment of acromegaly. Pituitary. 2011;14(2):157–162.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 498
Number of citations: 0